市場調查報告書
商品編碼
1297125
可吸收鼻腔植入物設備市場 - 按產品類型(藥物洗脫可吸收鼻腔植入物、非藥物洗脫鼻腔植入物)、按材料類型(聚合物、CMC)、按最終用途(醫院、門診手術中心)及2023-2032年預測Absorbable Nasal Implant Devices Market - By Product Type (Drug Eluting Absorbable Nasal Implants, Non-Drug Eluting Nasal Implants), By Material Type (Polymer, CMC), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast 2023 - 2032 |
到2032年,全球可吸收鼻腔植入設備市場規模將明顯擴大老年人鼻腔疾病的高發率增加了對可吸收鼻腔植入設備的需求。此外,全球範圍內醫療保健支出的增加促進了新型可吸收鼻腔植入設備的發展,補充了行業成長。事實上,在該領域經營的行業領導者正專注於產品創新以超越競爭。越來越多的戰略努力將在2023-2032年為可吸收的鼻腔植入設備行業帶來值得稱讚的收益。
整體市場佔有率根據產品、材料、最終用途和地區進行分類。
就產品而言,到2032年,非洗脫部分將以顯著的複合年成長率成長。這些設備的炎症減少,有利於它們的採用。這些植入物通常由生物相容性材料製成,隨著時間的推移會被身體吸收。隨著植入物的吸收,它減少了炎症或異物反應的風險。這可以使容易形成過多疤痕組織的病人或那些對異物有不良反應歷史的病人受益。
基於材料,羧基甲基纖維素(CMC)部分的市場價值將在2032年之前描繪出可觀的成長。這些植入物的多功能性和易用性支持其採用。它們可用於各種鼻部手術,包括鼻中隔整形術、隆鼻術和鼻部創傷重建。它們可以被塑造成適合每個病人的具體解剖要求的形狀,使它們在不同的手術應用中具有多樣性。
根據最終用途,非住院手術中心(ASCs)部分的可吸收鼻腔植入設備市場將在2032年之前大幅成長。 ASCs通常提供一個更個性化和以病人為中心的體驗。這些設施的規模較小,可以提供更多的個性化護理和關注。患者可以更直接地接觸到他們的手術團隊,從而使患者的滿意度和舒適度更高。此外,非住院手術中心數量的增加正在為該領域的成長創造有利可圖的機會。
從區域角度看,亞太地區可吸收鼻腔植入設備的市場佔有率將在2023年至2032年之間以顯著的複合成長率成長。鼻部疾病的發病率越來越高,加上醫療器械行業的蓬勃發展,為區域成長帶來了大量的機會。根據印度IBEF的數據,在22財年,該國醫療設備的出口價值為29.0億美元,預計到2025年將達到100億美元。
Global Absorbable Nasal Implant Devices Market size will expand significantly through 2032 High prevalence of nasal disorders in aging people has increased the demand for absorbable nasal implant devices. Moreover, increasing healthcare expenditure across the globe has fostered the development of novel absorbable nasal implant devices, supplementing industry growth. In fact, the industry leaders operating in the space are focusing on product innovations to outshine the competition. Increasing strategic efforts will bring commendable gains to the absorbable nasal implant devices industry over 2023-2032.
The overall market share is classified based on product, material, end-use, and region.
With respect to product, the non-eluting segment will grow at a significant CAGR through 2032. Reduced inflammation with these devices favors their adoption. These implants are typically made from biocompatible materials that are absorbed by the body over time. As the implant absorbs, it reduces the risk of inflammation or foreign body reactions. This can benefit patients prone to excessive scar tissue formation or those with a history of adverse reactions to foreign materials.
Based on material, the market value from the carboxy methyl cellulose (CMC) segment will depict considerable growth through 2032. The versatility and ease of use of these implants support their adoption. These can be used in various nasal procedures, including septoplasty, rhinoplasty, and nasal trauma reconstruction. They can be molded and shaped to fit the specific anatomical requirements of each patient, making them versatile for different surgical applications.
Based on end-use, absorbable nasal implant devices market from the ambulatory surgical centers (ASCs) segment will surge significantly through 2032. ASCs often provide a more personalized and patient-centered experience. The smaller size of these facilities allows for more individualized care and attention. Patients may have more direct access to their surgical team, resulting in higher level of patient satisfaction and comfort. Moreover, the growing number of ambulatory surgical centers is creating lucrative opportunities for segment growth.
From the regional perspective, the Asia Pacific absorbable nasal implant devices market share will grow at a notable CAGR between 2023 and 2032. Growing prevalence of nasal disorders, coupled with the flourishing medical device sector, is generating a plethora of opportunities for regional growth. As per India's IBEF, in FY22, the export of medical devices from the country was worth USD 2.90 billion and is projected to reach USD 10 billion by 2025.